Podocalyxin inhibits human embryo implantation in vitro and luminal podocalyxin in putative receptive endometrium is associated with implantation failure in fertility treatment

Objective: To study whether endometrial epithelial podocalyxin (PCX) inhibits implantation of human embryos in vitro and in patients undergoing in vitro fertilization (IVF). Design: We have recently identified PCX as a key negative regulator of endometrial epithelial receptivity. Podocalyxin is expressed in all epithelial cells in the nonreceptive endometrium, but is selectively downregulated in the luminal epithelium (LE) for receptivity. In the current study, we first investigated whether high levels of PCX in Ishikawa monolayer inhibit attachment and/or penetration of human blastocysts in i... Mehr ...

Verfasser: Heng, S.
Samarajeewa, N.
Aberkane, A.
Essahib, W.
Van de Velde, H.
Scelwyn, M.
Hull, M.L.
Vollenhoven, B.
Rombauts, L.J.
Nie, G.
Dokumenttyp: Journal article
Erscheinungsdatum: 2021
Verlag/Hrsg.: Elsevier
Schlagwörter: Endometrial receptivity / IVF / Podocalyxin / embryo implantation / epithelial receptivity / Endometrium / Cell Line / Blastocyst / Humans / Infertility / Sialoglycoproteins / Treatment Failure / Embryo Transfer / Fertilization in Vitro / Embryo Culture Techniques / Pregnancy Rate / Retrospective Studies / Fertility / Pregnancy / Victoria / Belgium / Female
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28944739
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/2440/133791